Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7492 p265
8 March 2008

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Pharmacists are “rubbish at gathering evidence”

Issues raised in discussion groups

Andy Murdock

Andy Murdock

Pharmacists are not good at gathering evidence for the work they undertake.

So said Andy Murdock, Lloydspharmacy’s pharmacy director, at a pharmacy engagement meeting for Lord Darzi’s NHS Next Stage Review for England, held in London last week.

Speaking as a member of Lord Darzi’s advisory group for the review, Mr Murdock declared: “From the outset, this process — not just what pharmacy is going through but the whole Darzi review — was to be based on evidence. That was made explicitly clear.”

He admitted that pharmacy was “rubbish at gathering evidence”, adding that this did not make his job promoting pharmacy on the advisory group easy.

Mr Murdock made a plea to primary care trusts, commissioners and service providers to make sure that meaningful outcomes are captured from any projects undertaken. “Doing so would make pharmacy’s job easier as a profession,” he said.

Speaking from the floor, Catherine Duggan, United Kingdom Clinical Pharmacy Association chairman, asked how innovation could best be spread when there is little existing evidence to support it.

Mr Murdock said: “If you are going to innovate there is no track record. It is about saying ‘is the case compelling enough to take the plunge and move forward?’.”

Ash Soni, London community pharmacist and a member of the pharmacy reference group supporting Mr Murdock’s role in the Darzi review, said: “When you innovate it is critical to recognise that one of the responsibilities of that innovation is to create the evidence base to support what you are doing. Use it as a vehicle to create evidence.”

Gul Root, principal pharmacist at the Department of Health, pointed out that if evaluation of a project shows benefit the results need to be published in peer-reviewed journals and that good practice should be spread.

“Pharmacists are generally not very good at publishing [results] in peer-reviewed journals, but if we do that we will build up the evidence base — and unless we have innovation I’m not sure where that evidence base will come from.”

A second event, hosted by Keith Ridge, chief pharmaceutical officer at the DoH, was held in Manchester this week.

Issues raised in discussion groups

At the London event pharmacists put forward various suggestions or needs in three discussion streams:

Long-term conditions
• Improved understanding of where pharmacy fits into the patient pathway

• Incentives for other healthcare professionals to work with pharmacy

• Government support for pharmacy engagement with practice-based commissioning

Urgent care
• A fully integrated electronic prescription service

• Minimum levels of service regardless of where a pharmacy is located

• Improved flow of information between GPs, pharmacy and NHS direct

• An up-to-date database with information on what pharmacy services are available and where they are

Staying healthy
• Establishment of a public health collaboration for pharmacy

• Improved public health learning at undergraduate and postgraduate level

• Better investment in training for pharmacists and pharmacy staff in the staying healthy agenda

• Local funding for long-term public health outcomes

Back to Top


©The Pharmaceutical Journal